Biopolym. Cell. 2017; 33(2):92-101.
Single center study of ESBL-related strains of Enterobacteriaceae collected from clinical specimens of infants with the congenital heart disease using multiplex PCR amplification
1Filonenko G. V., 1Talalaiev O. S., 2Kyryk D. L., 1Kovalenko N. O., 1Skorohod I. M., 1Salamanina A. O.
  1. Center for Pediatric Cardiology and Cardiac Surgery
    28./1, Chornovola Str. Kyiv, Ukraine, 01135
  2. P. L. Shupik National medical academy of post-graduate education
    9, Dorohozhytska Str., Kyiv, Ukraine, 04112


Aim. To study ESBL phenotypes, as well as to identify individual genotypes of β-lactamases and to study their prevalence among clinical strains of Enterobacteriaceae collected from children with the congenital heart disease. Methods. The susceptibility of clinical strains of Enterobacteriaceae to antibiotics was using an automated system; the resistance determinants were genotyped using multiplex PCR. Results. During the period of the study, 10.9 % of ESBL-positive isolates were found among clinical strains of Enterobacteriaceae. Most ESBL-producing strains (33.3 %) were Klebsiella pneumoniae. Most strains producing extended-spectrum β-lactamases were isolated from the respiratory tract and accounted for 83.3 %. Conclusions. This study provided new data on the prevalence of ESBL-producing genetic resistance determinants within the Enterobacteriaceae family and their role in the development of complications. We genotyped ESBL-positive isolates using multiplex PCR. The study demonstrated the diagnostic potential of molecular biology methods in identifying resistance determinants of microorganisms.
Keywords: antibiotic resistance, β-lactam antibiotics, Enterobacteriaceae, ESBL, PCR, genotyping


[1] Sievert DM, Ricks P, Edwards JR, Schneider A, Patel J, Srinivasan A, Kallen A, Limbago B, Fridkin S; National Healthcare Safety Network (NHSN) Team and Participating NHSN Facilities. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infect Control Hosp Epidemiol. 2013;34(1):1-14.
[2] Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev. 2005;18(4):657-86.
[3] Bush K, Fisher JF. Epidemiological expansion, structural studies, and clinical challenges of new β-lactamases from gram-negative bacteria. Annu Rev Microbiol. 2011;65:455-78.
[4] Stürenburg E, Mack D. Extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control. J Infect. 2003 ;47(4):273-95. doi:
[5] Ben-Ami R, Rodríguez-Baño J, Arslan H, Pitout JD, Quentin C, Calbo ES, Azap OK, Arpin C, Pascual A, Livermore DM, Garau J, Carmeli Y. A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients. Clin Infect Dis. 2009;49(5):682-90.
[6] Doi Y, Park YS, Rivera JI, Adams-Haduch JM, Hingwe A, Sordillo EM, Lewis JS 2nd, Howard WJ, Johnson LE, Polsky B, Jorgensen JH, Richter SS, Shutt KA, Paterson DL. Community-associated extended-spectrum β-lactamase-producing Escherichia coli infection in the United States. Clin Infect Dis. 2013;56(5):641-8.
[7] Moor CT, Roberts SA, Simmons G, Briggs S, Morris AJ, Smith J, Heffernan H. Extended-spectrum beta-lactamase (ESBL)-producing enterobacteria: factors associated with infection in the community setting, Auckland, New Zealand. J Hosp Infect. 2008;68(4):355-62. doi:
[8] Ojdana D, Sacha P, Wieczorek P, Czaban S, Michalska A, Jaworowska J, Jurczak A, Poniatowski B, Tryniszewska E.. The Occurrence ofblaCTX-M,blaSHV, andblaTEMGenes in Extended-Spectrumβ-Lactamase-Positive Strains ofKlebsiella pneumoniae,Escherichia coli, andProteus mirabilisin Poland. Int J Antibiot. 2014;2014:1–7.
[9] Sid Ahmed MA, Bansal D, Acharya A, Elmi AA, Hamid JM, Sid Ahmed AM, Chandra P, Ibrahim E, Sultan AA, Doiphode S, Bilal NE, Deshmukh A. Antimicrobial susceptibility and molecular epidemiology of extended-spectrum beta-lactamase-producing Enterobacteriaceae from intensive care units at Hamad Medical Corporation, Qatar. Antimicrob Resist Infect Control. 2016;5:4. doi:
[10] Al-Jassera AM. Extended-spectrum beta-lactamases (ESBLs): a global problem. Kuwait Medical Journal. 2006; 38( 3): 171-85.
[11] Monstein HJ, Ostholm-Balkhed A, Nilsson MV, Nilsson M, Dornbusch K, Nilsson LE. Multiplex PCR amplification assay for the detection of blaSHV, blaTEM and blaCTX-M genes in Enterobacteriaceae. APMIS. 2007;115(12):1400-8. doi:
[12] Paterson DL, Hujer KM, Hujer AM, Yeiser B, Bonomo MD, Rice LB, Bonomo RA; International Klebsiella Study Group. Extended-spectrum beta-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type beta-lactamases. Antimicrob Agents Chemother. 2003 ;47(11):3554-60. doi:
[13] Boyd DA, Tyler S, Christianson S, McGeer A, Muller MP, Willey BM, Bryce E, Gardam M, Nordmann P, Mulvey MR. Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extended-spectrum beta-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada. Antimicrob Agents Chemother. 2004;48(10):3758-64.
[14] Shah AA, Hasan F, Ahmed S, Hameed A. Characteristics, epidemiology and clinical importance of emerging strains of Gram-negative bacilli producing extended-spectrum beta-lactamases. Res Microbiol. 200;155(6):409-21. Review. doi:
[15] Guzmán-Blanco M, Labarca JA, Villegas MV, Gotuzzo E; Latin America Working Group on Bacterial Resistance. Extended spectrum β-lactamase producers among nosocomial Enterobacteriaceae in Latin America. Braz J Infect Dis. 2014;18(4):421-33. doi:
[16] Patel J, Everly M, Chang D, Kittleson M, Reed E, Kobashigawa J. Reduction of alloantibodies via proteasome inhibition in cardiac transplantation. J Heart Lung Transplant. 2011;30(12):1320-6. doi: Oct 2.
[17] Martins IS, Moreira BM, Riley LW, Santoro-Lopes G. Outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae infection among renal transplant recipients. J Hosp Infect. 2006;64(3):305-8. doi:
[18] Zowawi HM, Balkhy HH, Walsh TR, Paterson DL. β-Lactamase production in key gram-negative pathogen isolates from the Arabian Peninsula. Clin Microbiol Rev. 2013;26(3):361-80. doi:
[19] Garza-González E, Mendoza Ibarra SI, Llaca-Díaz JM, Gonzalez GM. Molecular characterization and antimicrobial susceptibility of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae isolates at a tertiary-care centre in Monterrey, Mexico. J Med Microbiol. 2011;60(Pt 1):84-90. doi:
[20] Sharma M, Pathak S, Srivastava P. Prevalence and antibiogram of Extended Spectrum β-Lactamase (ESBL) producing Gram negative bacilli and further molecular characterization of ESBL producing Escherichia coli and Klebsiella spp. J Clin Diagn Res. 2013;7(10):2173-7. doi:
[21] Giamarellou H, Poulakou G. Multidrug-resistant Gram-negative infections: what are the treatment options? Drugs. 2009;69(14):1879-901. doi: